Bullfrog AI Holdings, Inc. Common Stock (BFRG)

US — Healthcare Sector
Peers: HCTI  EUDA  MGRX  UTRS    FOXO  BEAT  NUTX  MPLN  ACON  AUGX  ETAO 

Automate Your Wheel Strategy on BFRG

With Tiblio's Option Bot, you can configure your own wheel strategy including BFRG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol BFRG
  • Rev/Share 0.0002
  • Book/Share 0.335
  • PB 4.9099
  • Debt/Equity 0.0
  • CurrentRatio 4.8631
  • ROIC -2.257

 

  • MktCap 15488539.0
  • FreeCF/Share -0.5683
  • PFCF -2.8127
  • PE -2.2427
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -1.6322

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Bullfrog AI Holdings, Inc. Common Stock (BFRG)

  • IPO Date 2023-02-13
  • Website https://www.bullfrogai.com
  • Industry Medical - Healthcare Information Services
  • CEO Mr. Vininder Singh
  • Employees 4

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.